Particularly, they found that the D1R expression and responsiveness are increased after L-DOPA treatment and that the sensitivity of the D1R signaling cascade is enhanced in L-DOPA-induced dyskinesias (Aubert et al., 2005). The gene discussed is DRD1; the disease is drug-induced dyskinesia.